Ambient Clinical Analytics, a provider of a data-driven, FDA Class II-cleared and CE-marked clinical decision support (CDS) platform for healthcare providers, raised $5 million in a strategic funding round led by Mairs & Power Venture Capital.
Ambient Clinical Analytics also announced the appointment of Brian Tufts as Chief Executive Officer, signaling a new phase of growth and market expansion.
Tufts will focus on expanding Ambient’s market presence, deepening strategic partnerships, and advancing the company’s mission to redefine how care teams operate in high-acuity environments.
Al Berning, the founder of Ambient Clinical Analytics, will transition to Executive Chairman, continuing to support the company’s long-term vision.
Brian Tufts, CEO of Ambient Clinical Analytics, said: “Hospitals do not lack data; yet doctors and nurses have few resources that deliver clarity in a dynamic clinical environment.”
“Ambient is addressing this challenge with our unique combination of real-time clinical analytics, clinical decision support, and workflow tools that meet clinicians where they are. Doctors and nurses love the support as these tools integrate seamlessly into their current practice,” added Brian Tufts.
According to the official press statement, Ambient Clinical Analytics will use new capital to accelerate innovation, expand adoption across health systems, and scale Ambient’s product, including its FDA Class II-cleared AWARE platform system. Built on clinically validated algorithms and Mayo Clinic–licensed technology, the company’s platform transforms complex clinical data into intuitive, actionable insights that support faster, more informed decision-making.
In the press statement, Ambient Clinical Analytics said its platform is already deployed across bedside care, command centers, and remote monitoring environments, helping healthcare organizations reduce variability in care delivery, improve clinical protocol adherence, and ultimately improve outcomes.